Tech billionaires who quietly used performance-enhancing drugs are now funding the "Enhanced Games"—Olympics for athletes on steroids.
This isn't about sports. It's about turning human optimization into a marketable product, with all the usual Silicon Valley promises about disruption and none of the usual concerns about consequences.
The Washington Post reports on a group of tech investors backing the Enhanced Games, a proposed international competition where performance-enhancing drugs are not just allowed but encouraged. The pitch is that drug bans in sports are hypocritical, outdated, and holding back human potential.
The investors include names from venture capital and crypto who've been open about their own use of performance enhancers—not for athletic competition, but for cognitive enhancement and longevity. They've been taking nootropics, peptides, and various gray-market substances for years. Now they want to normalize it for sports.
This has all the hallmarks of a Silicon Valley project that sounds innovative until you think about it for five minutes.
First, there's the libertarian framing. "Let athletes choose what to put in their bodies." That sounds like personal freedom until you realize that professional athletics doesn't work like that. When the sport allows doping, everyone has to dope to compete. It's not choice—it's coercion through competitive pressure.
Second, there's the health question. Performance-enhancing drugs have serious side effects, particularly at the doses required for elite competition. Anabolic steroids damage the cardiovascular system. EPO increases stroke risk. Growth hormone causes acromegaly. These aren't hypothetical risks—we've watched athletes die from doping complications.
Third, there's the question of what this does to sports as a concept. Part of what makes athletics compelling is watching what the human body can do through training, dedication, and natural ability. Strip that away and you're watching biochemistry compete, with humans as the delivery mechanism.
The investors will say this is about honesty—that athletes already dope, and we're just bringing it into the open. There's some truth to that. Drug testing in elite sports is a cat-and-mouse game that sophisticated athletes can beat. But the solution isn't to give up on fair competition; it's to get better at testing.
What's really happening here is that wealthy tech investors want to export their "biohacking" culture to mainstream sports. They've been experimenting on themselves—taking peptides, monitoring biomarkers, treating their bodies like systems to be optimized. And it's worked out fine for them, because they're rich and can afford medical supervision.
But that's not how sports work. Athletes, especially young athletes, will feel pressure to take whatever gives them an edge. The Enhanced Games might have medical oversight for its competitors, but what about the thousands of amateur athletes who try to emulate them?
The Olympics ban performance-enhancing drugs for good reasons. Not because the Olympic movement is naive about doping, but because allowing it would create a medical arms race that hurts more athletes than it helps.
The Enhanced Games is selling disruption. What it's actually selling is risk—packaged as human optimization, marketed as freedom, and ultimately profitable for the people who won't be taking the drugs themselves.
The technology—if you can call pharmaceutical doping that—is powerful. The question is whether anyone should be encouraging athletes to risk their health for our entertainment and investors' returns.
